Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shock to the system: new device helps stroke survivors walk better

NCT ID NCT06459401

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable device that uses mild electrical stimulation to help people who have had a stroke walk better. Ten participants with chronic stroke walked on a treadmill and overground with and without the device. The goal was to see if the stimulation could improve walking speed and make their steps more even. The results will help design better rehabilitation tools.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

Feb 2021

Finished

May 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of a stroke event occurring at least 6 months ago * Observable gait deficits * Independent ambulation for at least 30 meters (using an assistive device as needed but without a rigid brace or ankle foot orthosis) * Passive ankle dorsiflexion range of motion to neutral with the knee extended * Ability to follow a 3-step command * Resting heart rate between 40-100 bpm * Resting blood pressure between 90/60 and 170/90 mmHg * NIH Stroke Scale Question 1b score \> 1 and Question 1c score \> 0 * HIPAA Authorization to allow communication with healthcare provider * Medical clearance by a physician Exclusion Criteria: * Severe aphasia or inability to communicate with investigators * Neglect or hemianopia * Serious comorbidities that may interfere with ability to participate in the research (e.g. musculoskeletal, cardiovascular, pulmonary) * Pacemakers or similar electrical implants that could be affected by electrical stimulation * Metal implants directly under the stimulation sites * Pressure ulcers or skin wounds located near human-device interface sites * More than 2 unexplained falls in the previous month

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Neuromotor Recovery Laboratory

    Boston, Massachusetts, 02215, United States

  • Science and Engineering Complex

    Boston, Massachusetts, 02134, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.